Kathleen Dungan
Professor · Ohio State University Hospital
Credentials: · · · · ·
History
- 2001–2004
Internal Medicine
Research
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
New England Journal of Medicine · 2019 · 1,497 citations
Review · The Lancet · 2009 · First of 3 authors · Corresponding · 1,105 citations
The Lancet · 2014 · First of 7 authors · Corresponding · 404 citations
- EF
18 papers
13 papers
- KO
11 papers
10 papers
- GU
10 papers · 6 as a fellow
10 papers
8 papers
- LJ
7 papers
Grants
- 2020–2030
Epidemiology and Pathophysiology of Acute Pancreatitis-Related Diabetes Mellitus
National Institute of Diabetes and Digestive and Kidney Diseases · U01
PI · $1M · Ohio State University
- 2008–2014
Intensive Glycemic Control for Congestive Heart Failure Exacerbation
National Institute of Diabetes and Digestive and Kidney Diseases · K23
Contact PI · $748.4K · Ohio State University
- 2008–2012
Glycemic Control and Variability in Congestive Heart Failure Exacerbation
National Institute of Diabetes and Digestive and Kidney Diseases · R21
Contact PI · $412.5K · Ohio State University
Clinical trials
- 2022–2027
Continuous Glucose Monitoring Following Hospital Discharge
Principal investigator · Active not recruiting
Kathleen Dungan
- 2021–2022
Principal investigator · Completed
Ohio State University Comprehensive Cancer Center
- 2018–2020
Principal investigator · Terminated
Ohio State University
- 2014–2016
Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac Surgery
Principal investigator · Terminated · Phase 4
Kathleen Dungan